GAMP5 Annex 11 21 CFR Part 11
Science based approach
Identfy gaps
GAMP 5 2nd Edition is based on one key goal: to “protect patient safety, product quality, and data integrity by facilitating and encouraging the achievement of [computerized] systems that are effective, reliable, and of high quality.” The main issues highlighted in GAMP 5 2nd edition surround innovation, critical thinking, agile methodologies, and IT service management. The guidance shows a clear evolution from Computer Systems Validation (CSV) to Computer Software Assurance (CSA).
It's the ISPE's best practice guidance which has been accepted by regulators worldwide (including the FDA) and is widely referenced in their literature and documentation. A cost effective framework to ensure that computerised systems are fit for use and compliant with regulation.
GAMP 5 ® sets out guidelines for systems’ validation governed by five key concepts rooted in risk-based thinking.
GAMP 5 emphasizes a science based risk management approach to system validation and qualification. It encourages organizations to identify and assess potential risks associated with automated systems, allowing them to effectively allocate resources and prioritize validation activities.
GAMP 5 encourages organisations to have change management processes and robust procedures in place. Evaluating and controlling changes to automated systems helps to ensure that changes do not compromise product quality or patient safety.
In the early 1990s, the GAMP guide was mainly used to control suppliers of manufacturing production equipment to the pharmaceutical industry. Thus, the V model was used in the first four versions of the GAMP guide from 1994 to 2008. This V model worked very well for manufacturing equipment and equipment with computer control elements with simple configuration. But there are better-suited alternatives now.
With the recognition of agile methodology in GAMP 2nd Edition as a non-linear approach for software development and validation, legacy validation documents from GAMP 1st Edition, such as installation (IQ), operation (OQ), and performance qualification (PQ) documents, are no longer relevant.
Adhering to GAMP 5 guidelines offers several benefits to organisations:
Regulatory Compliance: GAMP 5 aligns with regulatory expectations and helps organisations demonstrate compliance with various regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Quality and Data Integrity: GAMP 5 ensures that automated systems consistently produce high-quality products while maintaining data integrity, fostering patient safety and trust in the industry.
Risk Mitigation: By adopting a risk-based approach, GAMP 5 helps organizations identify and mitigate potential risks associated with automated systems, minimizing the likelihood of product recalls, safety issues, and regulatory penalties.
Improved Efficiency: The lifecycle approach and emphasis on change management in GAMP 5 lead to more efficient system development, implementation, and maintenance. This results in reduced downtime, enhanced productivity, and decreased costs.
GAMP 5 outlines a risk based approach to Compliant GxP Computerised systems that can help manufacturers streamline their processes even as their regulatory obligations increase and supply chains become more complex.
